Research Article

Syndrome Differentiation of IgA Nephropathy Based on Clinicopathological Parameters: A Decision Tree Model

Table 5

Comparison of demographic and clinicopathological parameters between training and validation datasets.

Training dataset ()Validation dataset () value

Age (years)32 (27–42)31 (25–42)0.899
Female, (%)196 (53.0)47 (50.0)0.606
Disease course (months)6 (2–23)9 (1–21)0.946
Inducement, (%)
 Infection41 (11.1)16 (17.0)0.089
 Fatigue13 (3.5)3 (3.2)
 Pregnancy25 (6.8)1 (1.1)
 No obvious inducement291 (78.6)74 (78.7)
Systolic BP (mmHg)120 (110–132)127 (117–143)<0.001
Diastolic BP (mmHg)80 (70–86)84 (75–93)0.001
MAP (mmHg)93 (86–101)98 (90–107)<0.001
Hypertension, (%)136 (36.8)39 (41.5)0.285
Macroscopic hematuria, (%)66 (17.8)9 (9.6)0.052
U-RBC (/μL)45 (15–136)40 (13–172)0.798
Hemoglobin (g/L)128.2 ± 20.1128.2 ± 20.10.693
Proteinuria (g/day)1.0 (0.5–2.2)1.0 (0.5–2.4)0.764
Uric acid (μmol/L)340 (274–429)410 (328–519)<0.001
Serum albumin (g/L)40.3 (35.8–43.8)39.4 (35.3–42.9)0.238
Serum creatinine (μmol/L)79 (59–108)96 (72–151)<0.001
eGFR (mL/min/1.73 m2)97.2 (67.2–120.5)78.8 (50.5–109.3)<0.001
eGFR (mL/min/1.73 m2)
 <156 (1.6)5 (5.3)0.001
 >15, ≤3015 (4.1)9 (9.6)
 >30, ≤6053 (14.3)20 (21.3)
 >60, ≤9094 (25.4)22 (23.4)
 >90202 (54.6)38 (40.4)
Serum IgA (g/L)2.85 (2.25–3.58)2.99 (2.23–3.57)0.736
Serum C3 (mg/L)0.98 (0.87–1.11)1.05 (0.87–1.20)0.045
Oxford MEST scores
 M1, (%)361 (97.6)79 (86.8)<0.001
 E1, (%)54 (14.6)11 (12.1)0.538
 S1, (%)185 (50.0)55 (60.4)0.074
 T1, (%)193 (52.2)23 (25.3)<0.001
 T2, (%)68 (18.4)16 (17.6)

BP, blood pressure; MAP, mean arterial pressure; U-RBC, urinary red blood cell; eGFR, estimated glomerular filtration rate.